ACTR-21. UPDATED RESULTS OF A PHASE I DOSE-ESCALATION, DOSE-EXPANSION STUDY OF DISULFIRAM AND ADJUVANT TEMOZOLOMIDE FOR NEWLY DIAGNOSED GLIOBLASTOMA

Journal article

Open access

Peer reviewed

Jiayi Huang, Jian Campian, Amit Gujar, Christina Tsien, George Ansstas, David Tran, Todd Dewees, Albert Kim and A Craig Lockhart

Neuro-oncology (Charlottesville, Va.), Vol.19(Suppl 6), pp.vi5-vi5

2017-11

PMCID: PMC5692522

Abstract

Abstracts

url

https://doi.org/10.1093/neuonc/nox168.016View

Published (Version of record) Open

7 Record Views

Title: ACTR-21. UPDATED RESULTS OF A PHASE I DOSE-ESCALATION, DOSE-EXPANSION STUDY OF DISULFIRAM AND ADJUVANT TEMOZOLOMIDE FOR NEWLY DIAGNOSED GLIOBLASTOMA
Creators: Jiayi Huang - Washington University School of Medicine
Jian Campian - Washington University School of Medicine
Amit Gujar - Department of Neurosurgery, Washington University School of Medicine
Christina Tsien - Washington University School of Medicine
George Ansstas - Washington University School of Medicine
David Tran - University of Florida, Lilian Wells Department of Neurological Surgery
Todd Dewees - Washington University School of Medicine
Albert Kim - Department of Neurosurgery, Washington University School of Medicine
A Craig Lockhart - Washington University School of Medicine
Publication Details: Neuro-oncology (Charlottesville, Va.), Vol.19(Suppl 6), pp.vi5-vi5
Publisher: Oxford University Press
Academic Unit: Miller School of Medicine
Language: English
Resource Type: Journal article
PMCID: PMC5692522
Record Identifier: 991031600118002976